Elicio Therapeutics ELTX
NASDAQ ELTX
$1.90 -0.04 (-2.06%)
At close: Oct 23, 2026 · 4:00 PM EDT

Elicio Therapeutics (ELTX) Non Operating Investment Income (2023 - 2024)

Updated

Elicio Therapeutics' Non Operating Investment Income came in at $3,000 for FY2024.

Analysis

Elicio Therapeutics (ELTX) Non Operating Investment Income (2023 - 2024) Analysis & Trends

  • The FY2024 figure represents the lowest annual Non Operating Investment Income since FY2020.
  • Per Business Quant, earlier years put Non Operating Investment Income at -$58,000 in FY2020.
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Non-Op. Investment Inc. (Qtr)
1 Eli Lilly 1,137.66 Bn 1,106.24 Bn 19.71 Bn -
2 Johnson & Johnson 636.13 Bn 556.00 Bn 17.30 Bn -
3 AbbVie 505.28 Bn 478.39 Bn 12.70 Bn -
4 Merck 358.10 Bn 312.48 Bn 12.21 Bn -
5 Novartis Ag 292.59 Bn 256.58 Bn 11.24 Bn -
6 Astrazeneca 265.81 Bn 239.50 Bn 12.86 Bn -
7 Amgen 237.53 Bn 192.93 Bn 7.24 Bn -
8 Gilead Sciences 194.67 Bn 168.86 Bn 6.22 Bn -
9 Pfizer 171.17 Bn 117.82 Bn 10.94 Bn -
10 Elicio Therapeutics 36.66 Mn -40.96 Mn - -
Historic Data

Historic Data

Download Data
DateValue
Mar 31, 2024 3,000.00
Dec 31, 2023 105,000.00
Sep 30, 2023 -105,000.00
API Access

Elicio Therapeutics Non Operating Investment Income API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=non-operating-investment-income&ticker=ELTX&period=max&api_key=YOUR_API_KEY